|19.47||-0.06 / -0.31%|
As of 3:59pm ET
|19.47||-0.0023 / -0.01%|
The 6 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 40.50, with a high estimate of 48.00 and a low estimate of 22.00. The median estimate represents a +108.01% increase from the last price of 19.47.
The current consensus among 7 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.